Biomedical Engineering Reference
In-Depth Information
Objectives
and
deliverables
To search for and validate new biomarkers to accelerate
the competitive delivery of successful new technologies,
medicines, and therapies for prevention, early detection,
diagnosis, and treatment of disease. Efforts are focussed
in the areas of oncology, infl ammation and immunology,
metabolic disorders, and neurosciences:
•
Facilitate the discovery and development of
biomarkers using new and existing technologies
•
Validate their ability to diagnose disease, predict
therapeutic response, and modify medical practice
•
Identify patient groups who are better suited for a
particular intervention
•
Speed the approval of new therapeutic entities
•
Make consortium project results broadly available
Description of
consortium
The Biomarker Consortium is not a funding body; rather it
encourages the submission of biomarker project
concepts to the appropriate scientifi c steering committee,
composed of experts in each therapeutic area. When
approved, concepts are resubmitted as formal project
proposals to the executive committee. This group directs
the Biomarkers Consortium and is composed of the
founding partners and other stakeholders. Approved
projects receive the attention of consortium fundraising
activities within the Foundation for NIH (FNIH).
Time frame
Started October 2006, no specifi ed end date. One project
completed in 2009—adiponectin as a marker of
glycemic control
Current status
Projects currently funded through FNIH partnerships:
•
Fluorodeoxyglucose positron emission tomography
(FDG-PET) Lung and Lymphoma Projects interim
analysis due in 2010
•
Carotid magnetic resonance imaging (MRI)
reproducibility study will complete in 2010
•
Sarcopenia consensus summit to report in 2011
•
Alzheimer ' s disease (AD) proteomics project with
results end 2010
•
Analysis of placebo data from AD and mild cognitive
impairment
•
I - SPY2 trial launched in breast cancer
CARDIAC SAFETY RESEARCH CONSORTIUM (CSRC):
WWW.CARDIAC - SAFETY.ORG
Members
FDA, Health Canada, Duke University Clinical Research
Institute, New York Presbyterian Research Hospital,
GSK, Merck, Pfi zer, Abbott, Lilly, Quintiles, Mortara
Instrument, NeoCardio, Roche, Genentech
Search WWH ::
Custom Search